X0206 3 2017-07-12 0 0001653821 CEN BIOTECH INC CENBF 0001736937 Tarrabain Alex 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 Common Stock 49942 D Convertible Note 2016-10-26 2019-03-31 Common Stock 30000 D Alex Tarrabain (the "Reporting Person") was appointed to his position with CEN Biotech, Inc. (the "Issuer") on July 12, 2017 and owned 49,942 shares of the Issuer's common stock on such date and further held a $48,000 Convertible Promissory Note on such date which was convertible into 30,000 shares of the Issuer's common stock. On May 21, 2019, the Reporting Person was appointed as the Chief Financial Officer of the Issuer. The Reporting Person held a $48,000 Convertible Promissory Note issued on October 26, 2016 which was convertible into 30,000 shares of the Issuer's common stock. /s/ Alex Tarrabain 2021-04-22